Revenue: The sum of all revenue fields included for a company's operating activities.
Rapport Therapeutics, Inc. (RAPP) had Revenue of $20.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$20.00M |
$-19.86M |
|
-- |
|
$20.00M |
|
$44.22M |
|
$-24.21M |
|
$4.36M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-24.21M |
|
$-24.35M |
|
47.24M |
|
47.24M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$484.69M |
|
$2.52M |
|
$12.90M |
|
$497.60M |
|
$17.90M |
|
-- |
|
$8.19M |
|
$26.09M |
|
$471.51M |
|
$471.51M |
|
$471.51M |
|
47.81M |
|
| Cash Flow Statement Financials | |
$-13.06M |
|
$37.94M |
|
$0.53M |
|
$52.75M |
|
$78.16M |
|
$25.41M |
|
$6.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-121.08% |
|
-121.08% |
|
-- |
|
-99.28% |
|
-99.28% |
|
$-13.15M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
344.83 |
|
0.26 |
|
-4.21% |
|
-4.21% |
|
-3.99% |
|
-4.21% |
|
$9.86 |
|
$-0.28 |
|
$-0.28 |
|